Cargando…
Estimating the distribution of a novel clinical biomarker (FGF-23) in the US population using findings from a regional research registry
Evidence of involvement of novel biomarkers in disease pathogenesis from research cohorts often precedes an understanding of their distributions in broader populations. This study aimed to estimate the distribution of fibroblast growth factor 23 (FGF-23), an endocrine hormone that helps to regulate...
Autores principales: | Johnston, Joseph A., Nelson, David R., Zhang, Limin, Curtis, Sarah E., Voelker, James R., Wetterau, John R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597057/ https://www.ncbi.nlm.nih.gov/pubmed/31246994 http://dx.doi.org/10.1371/journal.pone.0218435 |
Ejemplares similares
-
FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019) -
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020) -
Scintigraphic Findings in FGF23-related Hypophosphatemic Osteomalacia
por: Fujita, Naoya, et al.
Publicado: (2023) -
Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011) -
FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)